Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 L-phenylalanine mustard (L-PAM): the first 25 years.

× No keyword cloud information.

22 in total

1. Structural characterization of melphalan modified 2'-oligodeoxynucleotides by miniaturized LC-ES MS/MS.

Authors: Bart Van den Driessche; Filip Lemière; Walter van Dongen; Eddy L Esmans
Journal: J Am Soc Mass Spectrom Date: 2004-04 Impact factor: 3.109

2. The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma.

Authors: U Loos; E Musch; M Engel; J H Hartlapp; E Hügl; H J Dengler
Journal: Eur J Clin Pharmacol Date: 1988 Impact factor: 2.953

3. A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma.

Authors: H K Osterheld; E Musch; G E von Unruh; U Loos; H Rauschecker; B J Mühlenbruch
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

4. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.

Authors: M J Yagi; J G Bekesi; M D Daniel; J F Holland; A De Barbieri
Journal: Cancer Chemother Pharmacol Date: 1984 Impact factor: 3.333

5. Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.

Authors: P E Noker; L Simpson-Herren; S D Wagoner
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

6. The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro.

Authors: Malin Wickström; Caroline Haglund; Henrik Lindman; Peter Nygren; Rolf Larsson; Joachim Gullbo
Journal: Invest New Drugs Date: 2007-10-06 Impact factor: 3.850

7. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.

Authors: M J Yagi; M Zanjani; J F Holland; J G Bekesi
Journal: Cancer Chemother Pharmacol Date: 1984 Impact factor: 3.333

8. Oral melphalan pharmacokinetics--relation to dose in patients with multiple myeloma.

Authors: H Ehrsson; S Eksborg; A Osterborg; H Mellstedt; A Lindfors
Journal: Med Oncol Tumor Pharmacother Date: 1989

9. Renal function in the elimination of oral melphalan in patients with multiple myeloma.

Authors: C G Adair; J M Bridges; Z R Desai
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

Review 10. Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors: A G Bosanquet
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333